Suchergebnisse - "Emberson, Jonathan"

PubPharm (290)

31

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

enthalten in: bioRxiv.org | 2023

von Horby, P. | Staplin, N. | Peto, L. | +36

32

Diabetes and infectious disease mortality in Mexico City

enthalten in: BMJ open diabetes research & care | 2023

von Bragg, F. | Kuri-Morales, P. | Berumen, J. | +15

33

Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK

enthalten in: PharmacoEconomics | 2023

von Zhou, J. | Wu, R. | Williams, C. | +10

34

Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK

enthalten in: PharmacoEconomics | 2023

von Zhou, J. | Wu, R. | Williams, C. | +10

35

Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK

enthalten in: PharmacoEconomics | 2023

von Zhou, J. | Wu, R. | Williams, C. | +10

36

Body Composition and Risk of Vascular-Metabolic Mortality Risk in 113 000 Mexican Men and Women Without Prior Chronic Disease

enthalten in: Journal of the American Heart Association | 2023

von Gnatiuc Friedrichs, L. | Wade, R. | Alegre-Díaz, J. | +13

37

Empagliflozin in Patients with Chronic Kidney Disease

enthalten in: The New England journal of medicine | 2023

von The EMPA-KIDNEY Collaborative Group | Herrington, W. | Staplin, N. | +137

CommentIn: Nat Rev Nephrol. 2023 Jan;19(1):3. - PMID 36450917

38

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

enthalten in: bioRxiv.org | 2022

von Horby, P. | Mafham, M. | Peto, L. | +31

39

Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease : Insights From Genetic Epidemiology

enthalten in: Hypertension (Dallas, Tex. : 1979) | 2022

von Staplin, N. | Herrington, W. | Murgia, F. | +11

CommentIn: Hypertension. 2022 Dec;79(12):2682-2684. - PMID 36350775

40

Higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

enthalten in: bioRxiv.org | 2022

von Horby, P. | Emberson, J. | Basnyat, B. | +34